AlphaCrest Capital Management’s Qiagen QGEN Stock Holding History

AlphaCrest Capital Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-139,421	Closed	-$4.87M	–	1347
2019 Q3	$4.87M	Buy	139,421 +121,017	+658%	+$4.66M	0.3%	32
2019 Q2	$791K	Buy	18,404 +11,998	+187%	+$497K	0.07%	507
2019 Q1	$276K	Buy	+6,406	New	+$258K	0.04%	683

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's QGEN Position: Q4 2019 in Review

AlphaCrest Capital Management sold out of Qiagen (QGEN) in Q4 2019, closing a stake of 139,421 shares — an estimated $4.87M sold.

AlphaCrest Capital Management first reported a position in QGEN in Q1 2019 and held it in 3 quarters. The position peaked at $4.87M in Q3 2019. 296 funds tracked by Wall St. Rank hold QGEN as of Q4 2019.

AlphaCrest Capital Management reported no remaining Qiagen position as of Q4 2019 after selling out during the quarter.
AlphaCrest Capital Management sold 139,421 Qiagen shares in Q4 2019, an estimated $4.87M.
AlphaCrest Capital Management first reported a position in Qiagen in Q1 2019 and held it in 3 quarters.
AlphaCrest Capital Management's Qiagen position peaked at $4.87M in Q3 2019.
296 funds tracked by Wall St. Rank held Qiagen as of Q4 2019.

Based on AlphaCrest Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.